Evaluation of clinical activity and functional impairment in smokers with ankylosing spondylitis

Rheumatology International

Volumn 25, Issue 5, 2005, Pages 357-360

  Kaan, Uzunca ^a   Ferda, Özdemir ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

Ankylosing spondylitis; BASDAI; BASFI; Smoking

Indexed keywords

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; BACKACHE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC TEST; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTION TEST; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; HUMAN; LABORATORY TEST; MALE; MEDICAL ASSESSMENT; PATIENT MOBILITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RADIODIAGNOSIS; RANK SUM TEST; RATING SCALE; SCORING SYSTEM; SMOKING; STATISTICAL SIGNIFICANCE;

ACTIVITIES OF DAILY LIVING; ADULT; COMORBIDITY; DISABILITY EVALUATION; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; SEVERITY OF ILLNESS INDEX; SMOKING; SPONDYLITIS, ANKYLOSING; TURKEY;

EID: 21644472085     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-004-0451-3     Document Type: Article

References (25)

1. Khan MA (1998) Ankylosing spondylitis: clinical features. In: Klippel JH, Dippe PA (eds) Rheumatology, 2nd edn, vol 1. Mosby, London, 6.16:1-10
2. Lipsky PE (1998) Spondyloarthropathies: etiology and pathogenesis. In: Klippel JH, Dippe PA (eds) Rheumatology, 2nd edn, vol 1. Mosby, London, 6.12:1-8
3. Ball GV (1993) Ankylosing spondylitis. In: McCarty DJ, Koopman WJ (eds) Arthritis and allied conditions, 12th edn, vol 1. Lea and Febiger, Malvern, 59:1051-1060
4. Wolheim FA (1993) Ankylosing spondylitis. In: Kelley WN, Harris ED, Ruddy S, Sledge C (eds) Textbook of rheumatology, 4th edn, vol 1. Saunders, Philadelphia, 56:943-960
5. Claudepierre P, Sibilia J, Roudot-Thoraval F, Flipo RM, Wendung D et al (1998) Factors linked to disease activity in a French cohort of patients with spondyloarthropathy. J Rheumatol 25:1927-1931
6. Moller P (1987) Seronegative arthritis - etiology and diagnosis. Scand J Rheumatol Suppl 66:119-127
7. Anonymous (1988) Public health survey on smoking. PIAR
8. Garret S, Jenkinson T, Kennedy G, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286-2291
9. Calin A, Garret S, Whitlock H, Kennedy LG, O'Shea J, Mallorie P (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281-2285
10. Ward MM (2002) Predictors of the progression of functional disability in patients with ankylosing spondylitis. J Rheumatol 29:1420-1425
11. Fergusson DM, Goodwill RD, Horwood LJ (2003) Major depression and cigarette smoking: results of a 21-year longitudinal study. Psychol Med 33:1357-1367
12. Berlin I, Singleton EG, Pedarriosse AM, Lancrenon S, Rames A, et al (2003) The Modified Reasons for Smoking Scale: factorial structure, gender effects and relationship with nicotine dependence and smoking cessation in French smokers. Addiction 98:1575-1583
13. Arday DR, Milton MH, Husten CG, Haffer SC, Wheeless SC et al (2003) Smoking and functional status among Medicare managed care enrollees. Am J Prev Med 24:234-241
14. Averns HL, Oxtoby J, Taylor HG, Jones PW, Dziedic K, Dawes (1996) Smoking and outcome in ankylosing spondylitis. Scand J Rheumatol 25:138-142
15. Doran MF, Brophy S, MacKay K, Taylor G, Calin A (2003) Predictors of long term outcome in ankylosing spondylitis. J Rheumatol 30:316-320
16. Viitanen JV, Heikkila S, Kokko ML, Kautiainen H (2000) Clinical assessment of spinal mobility measurements in ankylosing spondylitis: a compact set for follow-up and trials? Clin Rheumatol 19:131-137
17. Dalyan M, Guner A, Tuncer S, Bilgic A, Arasil T (1999) Disability in ankylosing spondylitis. Disabil Rehabil 21:74-79
18. Spoorenberg A, Van der Heijde D, de Klerk E, Dougados M, de Vlam K, Mielants H et al (1999) Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 26:961-965
19. Franssen MJ, Van de Putte LBA, Gribnau FWJ (1985) IgA serum levels and disease activity in ankylosing spondylitis. Ann Rheum Dis 44:766-771
20. Dougados M, Gueguen A, Nakache JP, Velicitat P, Zeidler H, Veys E et al (1999) Clinical relevance of C-reactive protein in axial involvement of ankylosing spondylitis. J Rheumatol 26:971-974
21. Laurent MR, Panayi GS (1983) Acute-phase proteins and serum immunoglobulins in ankylosing spondylitis. Ann Rheum Dis 42:524-528
22. Van der Heijde D, Calin A, Dougados M, Khan MA, Van der Linden S, Bellamy N et al (1999) Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS working group. J Rheumatol 26:951-954
23. Fisher LR, Cawley MID, Holgate ST (1990) Relation between chest expansion, pulmonary function, and exercise tolerance in patients with ankylosing spondylitis. Ann Rheum Dis 49:921-925
24. Harrison BJ, Silman AJ, Wiles NJ, Scott DG, Symmons DP (2001) The association of cigarette smoking with disease outcome in patients with early inflammatory polyarthritis. Arthritis Rheum 44:323-330
25. Mattey DL, Hutchinson D, Dawes PT, Nixon NB, Clarke S, Fisher J, Brownfield A, Alldersea J, Fryer AA, Strange RC (2002) Smoking and disease severity in rheumatoid arthritis: association with polymorphism at the glutathione S-transferase M1 locus. Arthritis Rheum 46:640-646